$ENZC is a multi-billion dollar biotech when they take a small % of the $30.5 BILLION DOLLAR HIV market
Monoclonal Antibody known as CLONE 3 has proven to be 95% effective in curing HIV in 5 labs (including Harvard) & is SUPERIOR to current toxic & costly ARVs
With a better product, $ENZC may just take the whole market.
And Big Pharma knows it.
Now do you see what's been going on here?
Big Pharma has been put on notice by the US Gov't (Trump getting cured with experimental monoclonal antibodies) and the Gates Foundation via their recent bombshell report: "Expanding Access to Monoclonal Antibody-Based Products: A Global Call to Action."
The Gates Foundation also started CoVIC: The Coronavirus Immunotherapy Consortium "to understand which antibodies are most effective against coronavirus, and to streamline and accelerate the research pipeline for antibody-based therapeutics needed." https://covic.lji.org
This united front between the US Gov't and Gates Foundation will lift prior restrictions on SUPERIOR NON-TOXIC MONOCLONAL ANTIBODIES and replace expensive, toxic pharmaceuticals that only seem to serve Big Pharma's bottom line (not patients).
There is a seismic shift happening.
$ENZC and any other companies far advanced in monoclonal antibodies are a good bet.
Given that Dr. Cotropia is the Godfather of Monoclonal Antibodies and he discovered CLONE 3 in 1989, its safe to say he's ahead of the curve and a sought out authority in this field. His company going public at this time is no coincidence. Expect multi-dollars.
Please wise up and know what you hold. This is all PUBLICLY AVAILABLE INFORMATION:
News 
Market Data 
Discover 
